Hepion Pharmaceuticals, Inc. - Common Stock (HEPA)

Last Price0.4400

Change-0.0500 (-10.20%)

NASDAQ · Last Trade: Apr 10th, 3:03 PM EDT

Hepion Pharmaceuticals (NASDAQ: HEPA) Reports Promising Phase 2 Trial Results for NASH Treatment

Renocofilstat's Positive Outcomes Reinforce Antifibrotic Action Hepion Pharmaceuticals, a clinical stage biopharmaceutical company focusing on AI-assisted therapeutic drug development, recently

Via Spotlight Growth · May 22, 2023